News for Biodesix, Inc. (BDSX)

New data from the INSIGHT study demonstrates the VeriStrat Host Immune Classifier (HIC)'s ability to predict overall survival in patients with non-small cell l

**media[634756]**

On May 21, 2025, renowned financial services firm Scotiabank announced an adjustment to its price target for Biodesix (BDSX). The price target was lowered from

Scotiabank has adjusted its price target for Biodesix (BDSX), lowering it from $3 to $2, while maintaining an Outperform rating on the stock. The revision follo

Biodesix, Inc. (BDSX) to attend two significant investor conferences in 2025. Presentation scheduled at the 45th Annual William Blair Growth Stock Confe

LOUISVILLE, Colo., May 21, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. ( BDSX), a leading diagnostic solutions company, today announced that members of the Biodes

**media[632694]**

Shares of Toll Brothers, Inc. TOL rose sharply in today's pre-market after the company posted stronger-than-expected earnings and sales results for the second q...

Biodesix (BDSX) to present data at ISPOR and ATS 2025 conferences highlighting the need for improved lung nodule management. Study of over 350,000 patie

**media[626720]**

Biodesix (BDSX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

U.S. stock futures declined on Tuesday following the worst trading day of 2025 on Monday. Futures fell in premarket trading except Nasdaq 100.

We recently published a list of 12 Penny Stocks with Insider Buying in 2025. In this article, we are going to take a look at where Biodesix, Inc.

Total Revenue: $71.3 million for 2024, a 45% increase year-over-year.Q4 Revenue: $20.4 million, a 39% increase over the prior year.Gross Margin: 78.2% for the

Mar 03, 2025 / 09:30PM GMTOperator Good day and thank you for standing by. Welcome to the biodesis. Q4 2024 earnings conference calls. (Operator Instructions) P

Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ETCompany ParticipantsChris Brinzey - Investor RelationsScott Hutton -...

Total Revenue of $71.3 million for FY2024, growing 45% over FY2023; Gross margins of 78% for FY2024, up 5% points over FY2023; FY2025 Total Revenue Guidance o

Quarterly Revenue: $20.4 million, surpassing the estimated $19.88 million.Annual Revenue: $71.3 million, a 45% increase over FY2023, driven by significant grow

**media[556088]**